Original paper
A hybrid of two major Blomia tropicalis allergens as an allergy vaccine candidate
Abstract
Introduction Allergen‐specific immunotherapy (AIT) represents a curative approach for treating allergies. In the tropical and subtropical regions of the world, Blomia tropicalis (Blo t 5 and Blo t 21) is the likely dominant source of indoor allergens. Aim To generate a hypoallergenic Blo t 5/Blo t 21 hybrid molecule that can treat allergies caused by B tropicalis . Methods Using in silico design of B tropicalis hybrid proteins, we chose two...
Paper Details
Title
A hybrid of two major Blomia tropicalis allergens as an allergy vaccine candidate
Published Date
May 13, 2020
Volume
50
Issue
7
Pages
835 - 847
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History